Year of publication
Type of material
Licence
Language
Synonyms were used for: bevacizumab
Search without synonyms: keywords:(bevacizumab)
Used synonyms:
- avastin
- cas 216974 75 3
- rhumab vegf
-
Impact of Pachychoroid and DRIL on the Treatment of Diabetic Macular Oedema with Intravitreal Bevacizumab
Thieme Verlag | 2024|Keywords: Bevacizumab, bevacizumab -
The addition of chloroquine and bevacizumab to standard radiochemotherapy for recurrent glioblastoma multiforme
Taylor & Francis Verlag | 2024|Keywords: bevacizumab -
Recovery of Therapeutically Ablated Engineered Blood‐Vessel Networks on a Plug‐and‐Play Platform
Wiley | 2024|Keywords: bevacizumab -
Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement
Wiley | 2024|Keywords: systemic bevacizumab -
Gastrointestinal perforation associated with bevacizumab in metastatic colorectal cancer
Free accessWiley | 2024|Keywords: bevacizumab -
A pharmacovigilance study of adverse event profiles and haemorrhagic safety of bevacizumab based on the FAERS database
Taylor & Francis Verlag | 2024|Keywords: bevacizumab -
Engineering Matrix-Free Drug Protein Nanoparticles with Promising Penetration through Biobarriers for Treating Corneal Neovascularization
American Chemical Society | 2024|Keywords: bevacizumab -
Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma
Karger Verlag | 2024|Keywords: Bevacizumab -
Pretreatment eosinophil count predicts response to atezolizumab plus bevacizumab therapy in patients with hepatocellular carcinoma
Wiley | 2024|Keywords: Atezolizumab plus bevacizumab -
Cost‐effectiveness analysis of continuing bevacizumab plus chemotherapy versus chemotherapy alone after first progression of metastatic colorectal cancer
Free accessWiley | 2024|Keywords: bevacizumab -
α‐FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
Wiley | 2024|Keywords: atezolizumab plus bevacizumab -
Chitosan surface modification modulates the mucoadhesive, permeation and anti-angiogenic properties of gellan gum/bevacizumab nanoparticles
Elsevier | 2024|Keywords: Bevacizumab -
Quality of life in ovarian cancer patients treated with bevacizumab: a meta-analysis
Taylor & Francis Verlag | 2024|Keywords: Bevacizumab -
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate‐stage hepatocellular carcinoma
Wiley | 2024|Keywords: atezolizumab plus bevacizumab -
Can low‐dose intravenous bevacizumab be as effective as high‐dose bevacizumab for cerebral radiation necrosis?
Free accessWiley | 2024|Keywords: intravenous bevacizumab -
Comparison of Efficacy and Safety of a Bevacizumab Biosimilar, in Combination with Chemotherapies, in Nonresectable Metastatic Colorectal Cancer and in Advanced Nonsquamous Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study
Free accessThieme Verlag | 2024|Keywords: bevacizumab -
Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab
Karger Verlag | 2024|Keywords: Atezolizumab plus bevacizumab -
Neoadjuvant S‐1 and oxaliplatin plus bevacizumab therapy for high‐risk locally advanced rectal cancer: A prospective multicenter phase II study
Free accessWiley | 2024|Keywords: bevacizumab -
Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment
Wiley | 2024|Keywords: bevacizumab -
Fam20C Kinase as a Key Regulator of Bevacizumab Resistance in Mesenchymal Glioblastoma
Wiley | 2024|Keywords: bevacizumab -
Evaluation of bevacizumab biosimilar on wound healing complications in patients with colorectal cancer undergoing endoscopic mucosal resection: A systematic review and meta‐analysis in anorectal medicine
Free accessWiley | 2024|Keywords: bevacizumab biosimilar -
Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore
Taylor & Francis Verlag | 2024|Keywords: bevacizumab -
Anatomical and Functional Results of Early or Late Switching from Anti-VEGF to Dexamethasone Implant in Case of Poor Anatomical Response in Naïve Patients with Macular Edema Secondary to Branch Retinal Vein Occlusion
Taylor & Francis Verlag | 2024|Keywords: bevacizumab -
Clinical Syndrome of Seizures, Headache, and Visual Blurring in Metastatic Carcinoma Colon
Free accessThieme Verlag | 2024|Keywords: bevacizumab -
Vascular endothelial growth factor (VEGF) antagonists for central retinal vein occlusion: an update on clinical progress
Taylor & Francis Verlag | 2024|Keywords: bevacizumab -
Efficacy and safety of bevacizumab in neoadjuvant and concurrent chemoradiotherapy for refractory cervical cancer patients
Free accessDOAJ | 2024|Keywords: bevacizumab -
Angioid Streaks Remain a Challenge in Diagnosis, Management, and Treatment
Free accessDOAJ | 2024|Keywords: bevacizumab -
Efficacy of Anti-VEGF Drugs Based Combination Therapies in Recurrent Glioblastoma: Systematic Review and Meta-Analysis
Bentham Science Publishers | 2024|Keywords: bevacizumab -
Antiangiogenic Therapeutic mRNA Delivery Using Lung-Selective Polymeric Nanomedicine for Lung Cancer Treatment
American Chemical Society | 2024|Keywords: Bevacizumab -
Cost-effectiveness and drug wastage of bevacizumab biosimilar with or without chemotherapy for platinum-resistant recurrent ovarian cancer
Taylor & Francis Verlag | 2024|Keywords: Bevacizumab biosimilar -
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
Free accessDOAJ | 2024|Keywords: Bevacizumab -
Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab
Free accessDOAJ | 2024|Keywords: bevacizumab -
The incidence of and risk factors for radiation pneumonitis in patients treated with simultaneous bevacizumab and thoracic radiotherapy
Free accessDOAJ | 2024|Keywords: Bevacizumab -
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)
Free accessDOAJ | 2024|Keywords: Bevacizumab -
A case report describing the use of systemic bevacizumab in the treatment of recurrent respiratory papillomatosis with pulmonary involvement
Free accessWiley | 2023|Keywords: avastin, bevacizumab -
Real‐world experiences of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma in Hong Kong
Free accessWiley | 2023|Keywords: bevacizumab -
A Case of Pneumothorax Required Surgical Treatment as a Complication of Paclitaxel with Bevacizumab Treatment
Free accessKarger Verlag | 2023|Keywords: Bevacizumab -
Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group
Online Contents | 2023|Keywords: Bevacizumab -
Risks of hypertension and thromboembolism in patients receiving bevacizumab with chemotherapy for colorectal cancer: A systematic review and meta‐analysis
Free accessWiley | 2023|Keywords: bevacizumab -
Long‐Term Follow‐up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis
Wiley | 2023|Keywords: avastin, bevacizumab -
Physicochemical stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin intravenous bags
Free accessDeGruyter | 2023|Keywords: Bevacizumab -
FOLFOX‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors
Wiley | 2023|Keywords: bevacizumab -
Postoperative bronchopleural fistula after induction therapy with bevacizumab
Free accessWiley | 2023|Keywords: bevacizumab -
Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib
Free accessWiley | 2023|Keywords: atezolizumab plus bevacizumab -
Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real‐world data
Wiley | 2023|Keywords: bevacizumab -
Bevacizumab for the early clinical progression of diffuse intrinsic pontine glioma
Wiley | 2023|Keywords: Bevacizumab
Send my search to (beta)
Send your search query (search terms without filters) to other databases, portals and catalogues to find more interesting hits.
Dimensions is a database for abstracts and citations that links information on research funding with the resulting publications, studies and patents.
In the TIB AV-Portal, audiovisual media from science and teaching can be foundand own scientific videos can be published.
The FID move can be used to search for subject-specific literature, research data and other information from mobility and transport research.
The Open Research Knowledge Graph provides structured descriptions of research content and makes it comparable.
Freely accessible part of the collaborative K10plus catalogue with materials relevant for interlibrary loan and direct delivery services.